Trials / Sponsors / Kerry Rogers
Kerry Rogers
Academic / Other · 3 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Pirtobrutinib (LOXO-305) and Venetoclax for the Treatment of Patients With CLL or SLL Resistant to Covalent BT Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Phase 2 | 2024-11-07 |
| Withdrawn | Ibrutinib and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia After Ibrutinib Resistance Chronic Lymphocytic Leukemia, Loss of Chromosome 17p | Phase 2 | 2020-03-11 |
| Active Not Recruiting | Bcl-2 Inhibitor GDC-0199 in Combination With Obinutuzumab and Ibrutinib in Treating Patients With Relapsed, Re Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia | Phase 1 / Phase 2 | 2015-08-03 |